Following an international career in the pharma industry (GSK, Sanofi, Oenobiol), Jean-Luc Treillou co-founded microbiome company LNC therapeutics in 2011, eventually raising 16.5M€ as CEO & Chairman. In 2018, he co-founded TreeFrog Therapeutics with Maxime Feyeux & Kevin Alessandri, taking in charge governance and investor...

TreeFrog Therapeutics was selected to join the French Tech 120 !   Launched by the French government, this program dedicated to startups in the hyper-growth phase offers unprecedented support to 123 fast-growing companies. By pooling the skills of numerous government agencies, ministries and public services, the French...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_empty_space height="64px"][vc_column_text] TreeFrog Therapeutics-すべての人に細胞治療を(幹細胞治療の会社) [/vc_column_text][vc_empty_space height="64px"][vc_column_text][/vc_column_text][vc_empty_space height="64px"][/vc_column][/vc_row][vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_empty_space height="64px"][vc_column_text] C-Stem™:幹細胞のカプセル化のメカニズムについて(TreeFrog Therapeutics) [/vc_column_text][vc_empty_space height="64px"][vc_column_text][/vc_column_text][vc_empty_space height="64px"][/vc_column][/vc_row][vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_empty_space height="64px"][vc_column_text] 幹細胞の大量生産のメカニズムについて [/vc_column_text][vc_empty_space height="64px"][vc_column_text][/vc_column_text][vc_empty_space height="64px"][/vc_column][/vc_row][vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_empty_space height="64px"][vc_column_text] C-Stem™:細胞治療のコスト削減のメカニズムについて [/vc_column_text][vc_empty_space height="64px"][vc_column_text][/vc_column_text][vc_empty_space height="64px"][/vc_column][/vc_row]...

Our CSO, Maxime Feyeux, contributed to a roundtable entitled "What breakthrough innovations to develop next-generation bioproduction factories ?" organized by BPI France and Medicen in Paris on October 10th 2019, during the Innogeneration event....

TreeFrog Therapeutics has developed C-Stem™ : a proprietary technology platform for the mass-production of iPSc-based cell therapies. C-Stem™ secures cell quality (100% genomic integrity), volumes (x100 cell amplification per week) and dramatically reduces cell therapy costs (by 10 today, by 100 tomorrow). Learn about C-Stem...

Just a short video released by the French Ministry of Higher Education, Research and Innovation after we were awarded the special prize "Coup de Coeur" of the i-LAB innovation contest !...